Det anbefales at udføre relevante laboratorieundersøgelser forud for behandling for at afdække subklinisk (asymptomatisk) nyre - eller leverlidelse som kan disponere for bivirkninger.
Appropriate laboratory testing is recommended prior to treatment in order to detect subclinical (asymptomatic) renal or hepatic disorders that may predispose to adverse effects.